Mizuho Reiterates Outperform Rating on Unity Biotechnology Inc (UBX)

March 25, 2025 4:47 AM UTC Send to a Friend
Mizuho analyst Salim Syed reiterated an Outperform rating and $6.00 price target on Unity Biotechnology Inc (NASDAQ: UBX)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login